BCP 8 Holdings Mozart Manager LLC

BCP 8 Holdings Mozart Manager LLC sold 33,317,824 shares ($1.2B) in 4 separate transactions at $36.54, reducing stake by -94.4%

BCP 8 Holdings Mozart Manager LLC executed 4 separate sales totaling 33,317,824 shares for $1,217,349,994.41, reducing its stake from 35,308,291 shares to 1,990,467 shares. The sales occurred at $36.54 per share, while the current price stands at $35.75, placing the stock -29.7% from its 52-week high of $50.88. Notably, the insider's prior 4 sales at MDLN were each well-timed at the 90-day mark (100.00% timing success rate at this ticker), with the pattern established by 4 identical transactions on 2026-03-10 each showing 90d returns of -9.8%, demonstrating the insider sold ahead of subsequent declines. The company's fundamentals show revenue of $7,352,000,000.00 with net income of $239,000,000.00 and annual revenue growth of +11.5%, yet the stock has declined -20.1% over 30 days and -19.5% over 90 days from this transaction date, establishing context for a near-complete exit position.

10% owner BCP 8 Holdings Mozart Manager L.L.C. sells 27,852,986 shares for $1.1B at $40.51, reducing holdings by 92.0% to 2.43M shares

BCP 8 Holdings Mozart Manager L.L.C., a principal 10% shareholder in Medline Inc., executed 4 separate sales totaling 27,852,986 shares for $1,128,268,756.88 on 2026-03-10, reducing its stake from 30,281,667 shares to 2,428,681 shares—a 92.0% reduction in holdings. The sales occurred at $40.51 per share against a current market price of $41.07, with the stock down 9.3% over the prior 30 days and trading 17.8% below its 52-week high of $49.99. This near-complete exit by a major insider holder occurs while the company reports robust 11.5% annual revenue growth, creating a meaningful divergence between fundamental performance and the shareholder's decision to substantially liquidate.